SEC Form 4 · accession 0001735276-18-000027
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael W Bonney
Director
Period of report
Jun 20, 2018
Accepted (ET)
Jun 22, 2018 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $105.26 | Jun 20, 2018 | A | 9,000 | A | Jun 20, 2019 | Jun 19, 2028 | Common Stock | 9,000 | 9,000 | D |